Arthex Biotech

    Approach: antisense oligonucleotides targeting microRNA

    Website

   Updates:

        July 23, 2020: Article discussing raise of 4.25 million euros in funding

        July 2021 study  Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy

        June 10, 2022 presentation for Myotonic Dystrophy Foundation